Joseph Cacciola

445 total citations
10 papers, 304 citations indexed

About

Joseph Cacciola is a scholar working on Hematology, Organic Chemistry and Oncology. According to data from OpenAlex, Joseph Cacciola has authored 10 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 4 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Joseph Cacciola's work include Blood Coagulation and Thrombosis Mechanisms (8 papers), Peptidase Inhibition and Analysis (4 papers) and Protease and Inhibitor Mechanisms (3 papers). Joseph Cacciola is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (8 papers), Peptidase Inhibition and Analysis (4 papers) and Protease and Inhibitor Mechanisms (3 papers). Joseph Cacciola collaborates with scholars based in United States and Germany. Joseph Cacciola's co-authors include John M. Fevig, Robert M. Knabb, Ruth R. Wexler, Richard Alexander, Karen A. Rossi, Pancras C. Wong, Patrick Y. S. Lam, Joseph M. Luettgen, Mimi L. Quan and Matthew Wright and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Organometallics.

In The Last Decade

Joseph Cacciola

10 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Cacciola United States 8 150 111 80 67 39 10 304
Lori L. Bostrom United States 9 149 1.0× 89 0.8× 107 1.3× 55 0.8× 34 0.9× 10 332
Shuaige Wang United States 8 171 1.1× 103 0.9× 80 1.0× 60 0.9× 16 0.4× 9 330
Zhaozhong J. Jia United States 14 270 1.8× 94 0.8× 173 2.2× 64 1.0× 41 1.1× 32 499
Noriyasu Haginoya Japan 17 184 1.2× 116 1.0× 248 3.1× 93 1.4× 43 1.1× 23 534
James R. Corte United States 13 227 1.5× 64 0.6× 102 1.3× 22 0.3× 39 1.0× 20 383
Keith Eagen United States 10 119 0.8× 72 0.6× 51 0.6× 32 0.5× 14 0.4× 15 218
John M. Fevig United States 13 381 2.5× 165 1.5× 173 2.2× 100 1.5× 71 1.8× 21 641
Martin C. Clasby United States 11 183 1.2× 82 0.7× 63 0.8× 59 0.9× 20 0.5× 22 325
Roopa Rai United States 9 221 1.5× 54 0.5× 96 1.2× 26 0.4× 26 0.7× 11 350
Taisuke Hamamoto Japan 9 122 0.8× 41 0.4× 115 1.4× 106 1.6× 48 1.2× 11 441

Countries citing papers authored by Joseph Cacciola

Since Specialization
Citations

This map shows the geographic impact of Joseph Cacciola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Cacciola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Cacciola more than expected).

Fields of papers citing papers by Joseph Cacciola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Cacciola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Cacciola. The network helps show where Joseph Cacciola may publish in the future.

Co-authorship network of co-authors of Joseph Cacciola

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Cacciola. A scholar is included among the top collaborators of Joseph Cacciola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Cacciola. Joseph Cacciola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Li, Yunlong, John M. Fevig, Joseph Cacciola, et al.. (2006). Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor Xa. Bioorganic & Medicinal Chemistry Letters. 16(19). 5176–5182. 24 indexed citations
2.
Fevig, John M., Joseph Cacciola, Karen A. Rossi, et al.. (2006). Preparation of 1-(4-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective and bioavailable inhibitors of coagulation factor Xa. Bioorganic & Medicinal Chemistry Letters. 16(14). 3755–3760. 43 indexed citations
4.
Cacciola, Joseph, John M. Fevig, Pieter F. W. Stouten, et al.. (2000). Synthesis and activity studies of conformationally restricted α-ketoamide factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(11). 1253–1256. 11 indexed citations
5.
Fevig, John M., Joseph Cacciola, Richard Alexander, et al.. (1998). Preparation of meta-amidino-N,N-disubstituted anilines as potent inhibitors of coagulation factor Xa. Bioorganic & Medicinal Chemistry Letters. 8(22). 3143–3148. 5 indexed citations
6.
Fevig, John M., Joseph Cacciola, Richard Alexander, et al.. (1998). Rational design of boropeptide thrombin inhibitors: β,β-dialkyl-phenethylglycine P2 analogs of DuP 714 with greater selectivity over complement factor I and an improved safety profile. Bioorganic & Medicinal Chemistry Letters. 8(3). 301–306. 32 indexed citations
7.
Cacciola, Joseph, Richard Alexander, John M. Fevig, & Pieter F. W. Stouten. (1997). The synthesis of lysine α-ketoamide thrombin inhibitord via an epoxy amide ring opening. Tetrahedron Letters. 38(33). 5741–5744. 5 indexed citations
8.
Cacciola, Joseph, John M. Fevig, Richard Alexander, et al.. (1996). Synthesis of conformationally-restricted boropeptide thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 6(3). 301–306. 17 indexed citations
9.
Galemmo, Robert A., John M. Fevig, David J. Carini, et al.. (1996). (N-acyl-N-alkyl)glycyl borolysine analogs: A new class of potent thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 6(24). 2913–2918. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026